As the COVID-19 pandemic continues to preoccupy infectious disease experts, Canadian researchers are raising an alarm about another serious public health concern: the lack of new antibiotics to treat drug-resistant infections in Canada. Lori Burrows is a Canada Research Chair in Microbe-Surface Interactions and professor of biochemistry and biochemical sciences at McMaster University. She tells us how Canada could solve this problem — and why it needs to do it fast.